Guillaume Gaud

Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8+ T Cell Anti-tumor Functions and Limits the Efficacy of Cancer Immunotherapy

Marianne Weulersse, Assia Asrir, Andrea Pichler et al. · Immunity · 2020 · 135 citations · Full text

Eomes-dependent Loss, Cancer Immunosurveillance, T-regulatory Cell +8

The costimulatory molecule CD226 signals through VAV1 to amplify TCR signals and promote IL-17 production by CD4 ⁺ T cells

Guillaume Gaud, Romain Roncagalli, Karima Chaoui et al. · Science Signaling · 2018 · 53 citations

Transient RNA silencing of tissue factor pathway inhibitor-2 modulates lung cancer cell invasion

Sophie Iochmann, Claire Bléchet, Valérie Chabot et al. · Clinical & Experimental Metastasis · 2009 · 43 citations

Cancer Research, Medicine, Transient Rna Silencing +10

Inhibition of cervical cancer cell growth by human papillomavirus virus–like particles packaged with human papillomavirus oncoprotein short hairpin RNAs

Latifa Bousarghin, Antoine Touzé, Guillaume Gaud et al. · Molecular Cancer Therapeutics · 2009 · 39 citations · Full text

EVER2 protein binds TRADD to promote TNF-α-induced apoptosis

Guillaume Gaud, Didier Guillemot, Yves Jacob et al. · Cell Death and Disease · 2013 · 33 citations · Full text